Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Israel stocks higher at close of trade; TA 25 up 0.87%

Published 2015-09-03, 11:00 a/m
Israel stocks higher at close of trade; TA 25 up 0.87%
TEVA
-
TA35
-
DLEKG
-
FRUT
-
ICL
-
NICE
-
TELBANK5
-
TACOMMIT
-
BIOMED
-
OPK
-

Investing.com – Israel stocks were higher after the close on Thursday, as gains in the Biomed, Communication and Banking sectors led shares higher.

At the close in Tel Aviv, the TA 25 gained 0.87%.

The best performers of the session on the TA 25 were OPKO Health Inc (TA:OPK), which rose 3.30% or 142 points to trade at 4451 at the close. Meanwhile, Teva (TA:TEVA) added 2.91% or 730 points to end at 25820 and ICL Israel Chemicals Ltd (TA:ICL) was up 2.78% or 64 points to 2365 in late trade.

The worst performers of the session were Nice (TA:NICE), which fell 2.39% or 570 points to trade at 23300 at the close. Delek Group (TA:DLEKG) declined 1.50% or 1440 points to end at 94260 and Frutarom (TA:FRUT) was down 1.29% or 190 points to 14500.

Rising stocks outnumbered declining ones on the Tel Aviv Stock Exchange by 184 to 147 and 119 ended unchanged.

Crude oil for October delivery was up 4.39% or 2.03 to $48.28 a barrel. Elsewhere in commodities trading, Brent oil for delivery in October rose 3.63% or 1.83 to hit $52.34 a barrel, while the December Gold contract fell 0.86% or 9.80 to trade at $1123.80 a troy ounce.

USD/ILS was up 0.30% to 3.9402, while EUR/ILS fell 0.88% to 4.3726.

The US Dollar Index was up 0.72% at 96.58.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.